[1] International Leprosy Association. The global situation of leprosy control at the beginning of the 21st Century. Int J Lepr, 2002, 70(1 Suppl):S21.
[2] World Health Organization. Action programme for the elimination of leprosy. Status report 1996. Geneva:WHO, 1996.
[3] World Health Organization. Weekly Epidemiological Record No. 1.Geneva:WHO, 2002.
[4] World Health Organization. Leprosy-global situation. Weekly Epidemio Rec. Geneva:WHO, 2002.1-8.
[5] World Health Organization. Action programme for the elimination of leprosy. Status report. Geneva:WHO, 1998.
[6] Hastings RC. Leprosy. 1st ed. New York:Churchill Livingstone,1985.
[7] World Health Organization. Guide to eliminate leprosy as a public health problem. first edition. Geneva:WHO, 2000.
[8] Saunderson P, Groenen G. Which physical signs help most in the diagnosis of leprosy? A proposal based on experience in the AMFES project, ALERT, Ethiopia. Lepr Rev, 2000,71:34-42.
[9] WHO Expert Committee on Leprosy. Sixth report. WHO Technicol Report Series. NO.768. Geneva:WHO, 1988.
[10] International Leprosy Association. The diagnosis and classification of leprosy. Int J Lepr, 2002,70(1 Suppl):S23-S32.
[11] WHO Expert Committee on leprosy. Seventh report, WHO Technical Report Series. NO. 874. Geneva:WHO, 1998.
[12] World Health Organization. Report on third meeting of the WHO technical advisory group on elimination of leprosy. Geneva:WHO,2002.29.
[13] Ellard GA.Drug compliance in the treatment of leprosy. Lepr Rev,1981,52:201-213.
[14] Ellard GA, Pannikar VK, Jesudasan K, et al. Clofazimine and dapsone compliance in leprosy. Lepr Rev, 1988,59:205-213.
[15] Baohong Ji. Leprosy elimination:beware of building monument on sand. Electronic letter published at www bmj.com
[16] Ji B. Does there exist a subgroup of MB patients at greater risk of relapse after MDT? Lepr Rev, 2001,72:3-7.
[17] Jamet P, Ji B. Relapse after long-term follow up of multibacillary patients treated by WHO multidrug regimen. Marchoux Chemotherapy Study Group. Int J Lepr Other Mycobact Dis, 1995,63:195-201.
[18] Girdhar BK, Girdhar A, Kumar A. Relapses in multibacillary leprosy patients:effect of length of therapy. Lepr Rev, 2000,71:144-153. |
